Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Acquisitions & Divestments (2016 - 2026)

Rockwell Medical filings provide 11 years of Change in Acquisitions & Divestments readings, the most recent being $7.2 million for Q4 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments changed N/A to $7.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.2 million, a 708.79% increase, with the full-year FY2025 number at $16.2 million, up 708.79% from a year prior.
  • Change in Acquisitions & Divestments hit $7.2 million in Q4 2025 for Rockwell Medical, up from $3.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $12.0 million in Q1 2022 to a low of $1.8 million in Q2 2023.
  • Median Change in Acquisitions & Divestments over the past 5 years was $4.1 million (2021), compared with a mean of $5.3 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: plummeted 57.15% in 2021 and later surged 77.68% in 2022.
  • Rockwell Medical's Change in Acquisitions & Divestments stood at $7.6 million in 2021, then decreased by 5.19% to $7.2 million in 2022, then tumbled by 44.52% to $4.0 million in 2023, then plummeted by 49.92% to $2.0 million in 2024, then soared by 259.46% to $7.2 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $7.2 million (Q4 2025), $3.0 million (Q3 2025), and $3.0 million (Q2 2025) per Business Quant data.